SI2174652T1 - Oralna farmacevtska sestava desmopresina - Google Patents

Oralna farmacevtska sestava desmopresina

Info

Publication number
SI2174652T1
SI2174652T1 SI200831737A SI200831737A SI2174652T1 SI 2174652 T1 SI2174652 T1 SI 2174652T1 SI 200831737 A SI200831737 A SI 200831737A SI 200831737 A SI200831737 A SI 200831737A SI 2174652 T1 SI2174652 T1 SI 2174652T1
Authority
SI
Slovenia
Prior art keywords
oral pharmaceutical
desmopressin
composition
desmopressin composition
oral
Prior art date
Application number
SI200831737A
Other languages
English (en)
Inventor
Navarro Nuria Carbajal
Montanes Antonio Boix
Abad Carlos Nieto
Duena Antonio Parente
Vizcaino Ricard Mis
Plumed Cesar Garcia
Original Assignee
Gp Pharm S.A.
Laboratorio Reig Jofre S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gp Pharm S.A., Laboratorio Reig Jofre S.A. filed Critical Gp Pharm S.A.
Publication of SI2174652T1 publication Critical patent/SI2174652T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI200831737A 2007-08-06 2008-08-01 Oralna farmacevtska sestava desmopresina SI2174652T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200702215A ES2319054B1 (es) 2007-08-06 2007-08-06 Composicion farmaceutica oral de desmopresina.
EP08805367.3A EP2174652B1 (en) 2007-08-06 2008-08-01 Oral pharmaceutical desmopressin composition
PCT/ES2008/000539 WO2009027561A2 (es) 2007-08-06 2008-08-01 Composición farmacéutica oral de desmopresina

Publications (1)

Publication Number Publication Date
SI2174652T1 true SI2174652T1 (sl) 2017-04-26

Family

ID=40032884

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831737A SI2174652T1 (sl) 2007-08-06 2008-08-01 Oralna farmacevtska sestava desmopresina

Country Status (18)

Country Link
US (1) US8993521B2 (sl)
EP (1) EP2174652B1 (sl)
JP (1) JP5626682B2 (sl)
CN (2) CN106265494A (sl)
AR (1) AR068337A1 (sl)
BR (1) BRPI0814835B8 (sl)
CY (1) CY1118459T1 (sl)
DK (1) DK2174652T3 (sl)
ES (2) ES2319054B1 (sl)
HR (1) HRP20161676T1 (sl)
HU (1) HUE032667T2 (sl)
LT (1) LT2174652T (sl)
MX (1) MX2010001456A (sl)
PL (1) PL2174652T3 (sl)
PT (1) PT2174652T (sl)
RU (1) RU2474414C2 (sl)
SI (1) SI2174652T1 (sl)
WO (1) WO2009027561A2 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
EP0381345B1 (en) * 1989-01-30 1994-07-13 Corint, Ltd. Aqueous liquid desmopressin-CMC pharmaceutical composition
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
IT1255460B (it) 1992-07-28 1995-11-02 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
RU2232608C2 (ru) * 1998-11-02 2004-07-20 Элзэ Копэрейшн Устройство для чрескожной доставки лекарственного средства электропереносом и способ его изготовления, способ чрескожной доставки лекарственного средства пациенту электропереносом
US6894026B1 (en) 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
ITMI20021684A1 (it) 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
EA012306B1 (ru) * 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
EP1473029B1 (en) 2003-04-30 2005-03-23 Ferring B.V. Solid dosage form comprising desmopressin
ES2243840T3 (es) 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
CN1878563A (zh) 2003-11-10 2006-12-13 西摩·H·费恩 包含低剂量去氨加压素的药物组合物
GB0406048D0 (en) 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US20050244502A1 (en) 2004-04-28 2005-11-03 Mathias Neil R Composition for enhancing absorption of a drug and method

Also Published As

Publication number Publication date
BRPI0814835B8 (pt) 2021-05-25
HUE032667T2 (en) 2017-10-30
BRPI0814835A2 (pt) 2015-03-31
PT2174652T (pt) 2016-12-23
ES2319054B1 (es) 2010-02-12
CY1118459T1 (el) 2017-07-12
WO2009027561A3 (es) 2009-07-16
EP2174652A2 (en) 2010-04-14
WO2009027561A2 (es) 2009-03-05
DK2174652T3 (en) 2017-01-23
RU2474414C2 (ru) 2013-02-10
CN106265494A (zh) 2017-01-04
EP2174652B1 (en) 2016-10-05
JP5626682B2 (ja) 2014-11-19
JP2010535745A (ja) 2010-11-25
AR068337A1 (es) 2009-11-11
RU2010105031A (ru) 2011-09-20
US8993521B2 (en) 2015-03-31
CN101808621A (zh) 2010-08-18
ES2319054A1 (es) 2009-05-01
PL2174652T3 (pl) 2017-06-30
HRP20161676T1 (hr) 2017-02-24
ES2608816T3 (es) 2017-04-17
BRPI0814835B1 (pt) 2020-10-27
US20110251123A1 (en) 2011-10-13
MX2010001456A (es) 2010-06-02
LT2174652T (lt) 2017-02-27

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
HK1136968A1 (en) Novel pharmaceutical composition
EP2222313A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA200905224B (en) Pharmaceutical composition
EP2116242A4 (en) NEW PHARMACEUTICAL COMPOSITION
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
GB0710439D0 (en) Oral dosage form
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2146695A4 (en) PHARMACEUTICAL COMPOSITIONS
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
GB0709811D0 (en) Pharmaceutical compositions
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
GB0707127D0 (en) Pharmaceutical compositions
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
IL205975A0 (en) Pharmaceutical composition
GB0712454D0 (en) Pharmaceutical compositions
EP2156842A4 (en) ORAL COMPOSITION
PT2174652T (pt) Composição farmacêutica oral de desmopressina
IL205931A0 (en) Pharmaceutical composition
GB0717036D0 (en) Pharmaceutical composition
GB0712558D0 (en) Pharmaceutical composition